ReviewFrontiers in neurology2022
Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure.
Navid Manouchehri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled itcites it